More than 51,000 units of toothpaste and mouthwash sold for children and adults have been recalled across the U.S. after federal testing found hormones in product samples, according to the Food and Drug Administration. The New York Post, citing Fox Business, and FOX6 News Milwaukee both reported on the recall, which involves six ORL Organic Oral Care products.
The FDA has classified the recall as Class II, a category the agency uses when a product may cause temporary or medically reversible health effects, or when serious harm is considered unlikely.
The recall covers 4-ounce tubes of ORL Organic Oral Care natural toothpaste in these flavors:
It also covers 16.9-ounce bottles of ORL mouthwash:
The products were distributed nationwide. The FDA enforcement report lists the specific lot numbers for each item.
The FDA said testing found progesterone, estradiol or dehydroepiandrosterone, known as DHEA, in samples. Progesterone and estradiol are primary female sex hormones. DHEA is a hormone the body uses to produce estrogen and testosterone.
The FDA report did not say which hormones turned up in which samples, or at what concentrations. It also did not explain how the contamination happened; the outlets described it as cross-contamination.
ORL Labs did not issue a press release about the recall. According to the FDA filing, the company notified its consignees or the public by letter. A company representative did not immediately respond to a request for comment from Fox Business.
Anyone with ORL Organic Oral Care toothpaste or mouthwash, including the kids’ flavors, can compare the product name, size, flavor, UPC and lot number on the package with the FDA enforcement report to see whether it falls under the recall. Because the recall covers items with expiration dates stretching to August 2028, products bought earlier or still on store shelves or in bathroom cabinets could be affected.
The FDA report did not include instructions on disposal or refunds. Consumers with questions can reach the company at 844-675-5227 or [email protected].
The Class II rating signals that the agency considers serious health consequences remote, though it does not rule out temporary or reversible effects. Because the FDA has not published the hormone levels found, it is not clear from the report how much of any hormone a person might have been exposed to.
Around Prague, based on reporting by New York Post, FOX6 News Milwaukee